Schedule 13G ownership disclosure

OUTLOOK THERAPEUTICS INC

Security class unavailable · CUSIP: 69012T206

Event date: 2020-02-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
133,818
Percent of class
0.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000074
Form type
SC 13G
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Feb 24, 2020
Reporting period
Feb 24, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub